ARTICLE | Financial News
Third Rock leads $30M CytomX round
September 24, 2010 12:12 AM UTC
CytomX Therapeutics (Santa Barbara, Calif.) raised $30 million in a series B round led by new investor Third Rock Ventures. New investor Roche Venture Fund also participated. CytomX is developing Prob...